Literature DB >> 11060106

Can pooling be used for seroprevalence studies of hepatitis C?

G M Stephens1, J M Raboud, L Karakas, C H Sherlock.   

Abstract

Two hepatitis C antibody assays were used to test diluted positive sera. Dilutions of 1 in 5, 1 in 10, and 1 in 20 all resulted in loss of reactivity, with the greatest losses occurring in samples with low and moderate reactivities. These results disqualify pooling as a strategy for seroprevalence studies and screening programs.

Mesh：

Substances：

Year:  2000        PMID： 11060106      PMCID： PMC87579     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Global programme on AIDS and global blood safety initiative. Recommendations for testing for HIV antibody on serum pools.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1991-11-01

2.  Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development.

Authors:  Z García; L Taylor; A Ruano; L Pavón; E Ayerdis; R B Luftig; K A Visoná
Journal:  J Med Virol       Date:  1996-07       Impact factor: 2.327

3.  A prospective study of a serum-pooling strategy in screening blood donors for antibody to hepatitis C virus.

Authors:  P Liu; Z X Shi; Y C Zhang; Z C Xu; H S Shu; X Y Zhang
Journal:  Transfusion       Date:  1997-07       Impact factor: 3.157

4.  Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries.

Authors:  J C Emmanuel; M T Bassett; H J Smith; J A Jacobs
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

5.  Use of pooling and outpatient laboratory specimens in an anonymous seroprevalence survey of HIV infection in British Columbia, Canada.

Authors:  C H Sherlock; S A Strathdee; T Le; D Sutherland; M V O'Shaughnessy; M T Schechter
Journal:  AIDS       Date:  1995-08       Impact factor: 4.177

6.  Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera.

Authors:  R L Kline; T A Brothers; R Brookmeyer; S Zeger; T C Quinn
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948
  6 in total
  1 in total

1.  Group testing case identification with biomarker information.

Authors:  Dewei Wang; Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Comput Stat Data Anal       Date:  2018-02-01       Impact factor: 1.681
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.